Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

KIDS vs TNDM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TNDM Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 4–4 Matrix Metrics)

TNDM Overall Winner 6-Pillar Tally: KIDS 3 – 3 TNDM Matrix Metrics: KIDS 4 – 4 TNDM

As of Nov 19, 2026, Tandem Diabetes Care, Inc. (TNDM) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas TNDM carries 30.8/100 (SELL) at $16.80 (N/M Forward P/E, -2.4% operating margin).

  • Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. TNDM 30.8/100 SELL), TNDM captures the overall institutional head-to-head verdict (4–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-2.4% vs. -8.2% operating margin) and revenue trajectory (+13.8% vs. +18.6% YoY).
  • Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile TNDM is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 44.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KIDS vs TNDM
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86
TNDM NASDAQ Head-to-Head Winner
Tandem Diabetes Care, Inc.
Surgical & Medical Instruments & Apparatus
$16.80
-1.47% 1D
Market Cap $1.2B
TTM Revenue $1.08B
Forward P/E N/M
Beta / 30D Vol 1.21β · 94% Vol
Unified Composite Score
30.8 / 100 SELL
Tech 20.0 Fund 37.0 Flow 69.0 Mom 11.1
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -6.8%) with fading momentum, RSI 45
RSI-14: 44.6 · SMA20: $18.35 · SMA50: $17.24

6-Pillar Scorecard Institutional Category Breakdown (KIDS 3 – 3 TNDM)

Columns: Metric · KIDS · TNDM
1. Valuation Multiples TNDM
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 3.2x 1.7x
2. Growth & Scale KIDS
Revenue Growth (YoY) +18.6% +13.8%
Earnings Growth (YoY) +0.0% -37.0%
TTM Revenue (USD) $264M $1.08B
Market Cap $850.2M $1.2B
3. Profitability & Quality TNDM
Gross Margin 73.8% 56.6%
Operating Margin -8.2% -2.4%
Net Profit Margin -12.8% -4.6%
Return on Equity (ROE) -9.8% -36.7%
4. Balance Sheet & Cash Flow KIDS
Cash Generation (TTM) $1.1M EBITDA -$71M
Cash Flow Margin 0.4% EBITDA Mgn -6.6%
Net Cash / Leverage $12.99 Book/Sh · -9.8% ROE $664M Net Debt (5.45x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning TNDM
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 145.1% (100th %ile) 193.7% (45th %ile)
Put/Call OI Skew N/A 0.45x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Distribution
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 82.0% of Rev ($217M) 59.0% of Rev ($635M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KIDS (4) vs TNDM (4)
Institutional Metric KIDS TNDM Criterion Row Edge
Market Capitalization
Scale
$850.2M $1.2B Larger Scale TNDM
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+18.6% +13.8% Higher Growth KIDS
Operating Margin (TTM)
Profitability
-8.2% -2.4% Higher Margin TNDM
Net Profit Margin
Profitability
-12.8% -4.6% Higher Margin TNDM
Return on Equity (ROE)
Capital Efficiency
-9.8% -36.7% Higher ROE KIDS
52-Week Range Position
Momentum
90% ($14–$35) 26% ($12–$30) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
0.81β · 108% Vol 1.21β · 94% Vol Lower Realized Risk TNDM
Unified Institutional Score
Composite Signal
45.1 / 100 (HOLD) 30.8 / 100 (SELL) Higher Composite KIDS
Trailing 12M Revenue (USD)
Operating Scale
$264M $1.08B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.8% 56.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev N/M PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) -$71M ($664M Net Debt (5.45x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +33.62 pp
KIDS: +36.37% · TNDM: +2.75%
3M Horizon KIDS +51.47 pp
KIDS: +26.74% · TNDM: -24.73%
6M Horizon KIDS +69.8 pp
KIDS: +76.4% · TNDM: +6.6%
1Y Horizon KIDS +109.05 pp
KIDS: +98.84% · TNDM: -10.21%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs TNDM. Trailing 12-month operating profitability (KIDS -8.2% vs TNDM -2.4%) and valuation multiples (KIDS N/M vs TNDM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M
TNDM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.08B
Gross Margin56.6%
Op. Margin-2.4%
ROE / Fwd P/E-36.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TNDM BREAKDOWN
71d in phase · OBV ACCUMULATION
Current IV 193.7%
IV Percentile 45th %ile
Put/Call OI Skew 0.45x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact TNDM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published
TNDM Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $1.2B market capitalization and -2.4% operating margin.
OpEx & R&D Reinvestment 59.0% of Rev ($635M)
90D Engineering Disclosures 0 Published

Investor FAQ KIDS vs TNDM Key Questions & Quantitative Answers

As of Nov 19, 2026, Tandem Diabetes Care, Inc. (TNDM) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas TNDM carries 30.8/100 (SELL) at $16.80 (N/M Forward P/E, -2.4% operating margin). Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. TNDM 30.8/100 SELL), TNDM captures the overall institutional head-to-head verdict (4–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-2.4% vs. -8.2% operating margin) and revenue trajectory (+13.8% vs. +18.6% YoY). Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile TNDM is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 44.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with TNDM at +13.8% YoY revenue growth and -37.0% YoY earnings growth on $1.08B TTM revenue (56.6% gross margin, -2.4% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $1.08B for TNDM. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus 59.0% of Rev ($635M) (0 disclosures) for TNDM.

TNDM screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas TNDM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-6.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus TNDM (-36.7% ROE) capital efficiency.

In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, TNDM carries 193.7% implied volatility (45th %ile, Balanced (25th–60th %ile)), a 0.45x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.21β · 94% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.